Mondobiotech Holding AG Company presentation

Our approach to drug discovery
• In today’s world, scientific and medical information is extremely fragmented and dispersed throughout
millions of publications. Our technology makes it accessible and retrievable at low cost
• In fact, our internally-developed bio-mathematical methodology platform enables us to structure a
vast amount of validated and qualified information onto knowledge-based cloud, allowing our
scientists to connect information on rare diseases with a knowledge of biologically-active peptides
• The platform provides the rationale for new or “redirected” uses of peptides against rare diseases
• As many companies are cutting or externalizing R&D costs, Mondobiotech is delivering a steady stream
of medicinal products for early clinical development
7